2018
DOI: 10.12988/bmgt.2018.811
|View full text |Cite
|
Sign up to set email alerts
|

Promising utilities of growth differentiation factor 15 in cardiovascular diseases

Abstract: Recent clinical trials have shown that biological markers presumably natriuretic peptides, galectin-3, soluble ST2 could be the best tool for cardiovascular (CV) risk stratification in general population as well as in individuals with CV diseases. However, abilities of these biomarkers to predict CV mortality rate are variable and depends on age, sex, kidney function and metabolic comorbidities. Growthdifferentiation factor-15 (GDF-15) belongs to the transforming growth factor-β superfamily that regulates mito… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 29 publications
(38 reference statements)
0
1
0
Order By: Relevance
“…There are many types of congenital heart diseases. Most affect the walls, valves, or blood vessels; some are serious and may need several surgeries and treatment (Berezin et al, 2018).…”
Section: Introductionmentioning
confidence: 99%
“…There are many types of congenital heart diseases. Most affect the walls, valves, or blood vessels; some are serious and may need several surgeries and treatment (Berezin et al, 2018).…”
Section: Introductionmentioning
confidence: 99%